Biopharmaceuticals Market
Report ID: SQMIG35H2058
Biopharmaceuticals Market Updates
Skyquest Technology's expert advisors continuously track and analyze the latest developments and updates related to biopharmaceuticals market. Our team of analysts stay abreast of all the recent news stories shaping the industry including new product launches by major companies, strategic partnerships, M&As, Patent filings and industry and regulatory developments.
Biopharmaceuticals Market News
in Biopharmaceuticals Market
- In 2025, significant organizational changes within the U.S. Food and Drug Administration (FDA), including leadership transitions and restructuring, have led several biotechnology firms to consider conducting early-stage clinical trials outside the United States. This shift aims to mitigate potential delays in regulatory reviews, with companies exploring alternative pathways in regions like the European Union and Australia.
- By 2024, investment in gene therapy witnessed a substantial decline, raising only $1.4 billion compared to $8.2 billion in 2021. Challenges such as high treatment costs, complex manufacturing processes, and safety concerns contributed to this downturn. Conversely, the market for weight-loss drugs experienced a surge in investor interest, with projections estimating annual sales to reach $150 billion, drawing attention away from gene therapy ventures.
- The adoption of single-use technologies in biopharmaceutical manufacturing has seen significant growth, with the market valued at $6.5 billion in 2024 and projected to reach $11.2 billion by 2029. This expansion is driven by the increasing demand for monoclonal antibody production, the launch of new products, and the growing emphasis on personalized medicine.
Biopharmaceuticals Market Report Snapshots
REQUEST FOR SAMPLE
Want to customize this report?
REQUEST FREE CUSTOMIZATION
REQUEST FREE CUSTOMIZATION
USA (+1) 351-333-4748
